Chemomab Therapeutics (CMMB) Other Working Capital Changes (2018 - 2023)
Chemomab Therapeutics posted quarterly Other Working Capital Changes of -$896000.0 for Q4 2023, down 1234.18% year-on-year from $79000.0 in Q4 2022, and down 89500.0% on a QoQ basis from -$1000.0 in Q3 2023.
Chemomab Therapeutics (CMMB) has 6 years of Other Working Capital Changes data on file, last reported at -$896000.0 in Q4 2023.
- For the quarter ending Q4 2023, Other Working Capital Changes fell 1234.18% year-over-year to -$896000.0; the trailing twelve-month figure through Dec 2023 stood at -$903000.0 (down 1510.94% YoY), and the FY2025 full-year result was $1.1 million, up 134.7% from the prior year.
- Other Working Capital Changes for Q4 2023 stood at -$896000.0, down from -$1000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.5 million in Q4 2019 and bottomed at -$3.0 million in Q3 2019.
- The 5-year median for Other Working Capital Changes is -$1500.0 (2021), against an average of -$169277.8.
- The widest annual swing landed in 2022, when Other Working Capital Changes soared 4050.0%; it then plunged 6883.33% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at $2.5 million in 2019, then plunged by 97.34% to $67000.0 in 2020, then tumbled by 102.99% to -$2000.0 in 2021, then jumped by 4050.0% to $79000.0 in 2022, then slumped by 1234.18% to -$896000.0 in 2023.
- The last three Other Working Capital Changes figures came in at -$896000.0 (Q4 2023), -$1000.0 (Q3 2023), and $808000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -896,000.00 |
| Dec 31, 2023 | -896,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | 808,000.00 |
| Jun 30, 2023 | 808,000.00 |
| Mar 31, 2023 | -814,000.00 |
| Mar 31, 2023 | -814,000.00 |
| Dec 31, 2022 | 79,000.00 |
| Dec 31, 2022 | 79,000.00 |
| Jun 30, 2022 | -27,000.00 |
| Jun 30, 2022 | -27,000.00 |
| Mar 31, 2022 | 12,000.00 |
| Mar 31, 2022 | 12,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Jun 30, 2021 | 57,000.00 |
| Jun 30, 2021 | 57,000.00 |
| Mar 31, 2021 | -57,000.00 |
| Mar 31, 2021 | -57,000.00 |
| Dec 31, 2020 | 67,000.00 |
| Dec 31, 2020 | 67,000.00 |
| Sep 30, 2020 | -29,000.00 |
| Sep 30, 2020 | -29,000.00 |
| Jun 30, 2020 | 9,000.00 |
| Jun 30, 2020 | 9,000.00 |
| Mar 31, 2020 | 52,000.00 |
| Mar 31, 2020 | 52,000.00 |
| Dec 31, 2019 | 2.52 Mn |
| Dec 31, 2019 | 2.52 Mn |
| Sep 30, 2019 | -3.00 Mn |
| Sep 30, 2019 | -3.00 Mn |
| Jun 30, 2019 | -330,000.00 |
| Jun 30, 2019 | -330,000.00 |
| Mar 31, 2019 | -1.50 Mn |
| Mar 31, 2019 | -1.50 Mn |
| Dec 31, 2018 | -244,000.00 |
| Dec 31, 2018 | -244,000.00 |
| Sep 30, 2018 | 93,000.00 |
| Sep 30, 2018 | 93,000.00 |